News Room

Prescient thought leaders are available to comment on a variety of healthcare and industry-related topics. For more information or to connect to a subject matter expert or thought leader, please contact info@prescienthg.com.
In the News

Prescient Advisory Announces Recent Appointments to the Senior Team

Posted on 2020/02/10

Prescient announces the recent appointment of two new senior members, Kevin Baruzzi and Dr. Arun Shrivats, to its Advisory business. They join our specialist team focused on helping clients develop and commercialize assets and brands that resonate in the market and differentiate from the competition[...] Read More

Twitter Feed

#COVID19 – While defense against potential impact is the default response, the current situation could also provide significant differentiation opportunities in #biopharma that need to be explored. Read more at https://t.co/QCehw5jen7

As congresses begin announcing their virtual content, it is evident that we'll still have access to the information needed to understand the implications of the latest developments in science, clinical data and trends. Read more about how we can help you: https://t.co/yCsXPD98AW

The Pharma Fast 50 – 2020

Prescient Healthcare Group has been recognized, for the third year in a row, as one of the 50 fastest-growing privately owned pharma companies in the UK.

Quality Progress Report: Monitoring COVID-19

Prescient’s Dr. Julia Seaman shares her thoughts on monitoring COVID-19 in the American Society for Quality’s March Issue of Quality Progress.

Prescient announces the opening of its Boston office

Prescient is proud to share the exciting news that we will be officially opening a Boston office!

2020 Pharma CI Europe Conference

Prescient will be in Zurich for the 2020 Pharma CI Europe Conference and Exhibition on March 19-20, 2020.On Thursday, March 19, at 2:55 PM, Prescient will lead a podium session.

2020 Biocom Global Life Sciences Partnering Conference

The 2020 Biocom Global Life Sciences Partnering Conference will be held from February 25-27, 2020 in La Jolla, California. The event is an exclusive partnering forum that provides senior executives, bankers, venture capitalists, and business development professionals from leading pharmaceutical and biotech companies around the globe to network and conduct business.

Manuscript: Mechanosensitive Ca2+ signaling and coordination is diminished in osteocytes of aged mice during ex vivo tibial loading

This work used a novel ex vivo model to demonstrate diminished mechanosensing and lack of signaling coordination in aged osteocyte networks in live bone, which may contribute to pathology of age-induced bone loss.

Manuscript: AAV1.SERCA2a Gene Therapy Reverses Pulmonary Fibrosis by Blocking the STAT3/FOXM1 Pathway and Promoting the SNON/SKI Axis

The American Society of Gene and Cell Therapy has accepted and published a manuscript from Prescient’s Carly Jones in Molecular Therapy

LeadingBiotech – East/West CEO 2020 (San Francisco)

LeadingBiotech’s East/West CEO will be held during January 11-12, 2020, in San Francisco. The event brings together global leaders in the biopharma community to network and share insights on the industry outlook for the year ahead. Dr. Mark Little and Dr. Julia Seaman will be attending the event on behalf of Prescient.

2019 ASBMR Young Investigator Award

Prescient’s Andrea Campi has been recognized with the ASBMR Young Investigator Award. The American Society for Bone and Mineral Research (ASBMR) is a professional, scientific and medical society established to bring together clinical and experimental scientists who are involved in the study of bone and mineral metabolism.

2019 Pharma CiMi.CON USA

The 2019 annual Pharma CiMi.CON will be held on November 7-8 in Boston. Dr. Mark Little will attend this event on behalf of Prescient. The event will bring together more than 120 competitive and market intelligence professionals for networking and exchange, to discuss key industry topics and to create new partnerships.